###begin article-title 0
###xml 136 151 136 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 136 150 <span type="species:ncbi:8355">Xenopus laevis</span>
Identification of a novel conserved mixed-isoform B56 regulatory subunit and spatiotemporal regulation of protein phosphatase 2A during Xenopus laevis development
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 645 653 616 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
Wnt signaling is a key regulator of development and tumorigenesis. Protein phosphatase 2A (PP2A), which consists of a catalytic C, a structural A, and a regulatory B subunit, plays diverse roles in Wnt signaling through its B56 subunits. B56 is a multigene family encoding for proteins with a conserved core domain and divergent amino- and carboxy-termini. Ectopic B56alpha and B56gamma reduce beta-catenin abundance and B56alpha reduces Wnt-dependent transcription, suggesting that B56alpha and B56gamma inhibit Wnt signaling. In contrast, B56epsilon is required for Wnt signaling. Knowledge of where and when B56 subunits are expressed during Xenopus development will aid in our understanding of their roles in Wnt signaling.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 67 81 59 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 93 101 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 150 158 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1232 1240 1150 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 67 81 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 189 194 <span type="species:ncbi:9606">human</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
###xml 719 724 <span type="species:ncbi:9606">human</span>
We have undertaken expression analyses of B56alpha and B56gamma in Xenopus laevis. We cloned Xenopus B56alpha; it is 88% identical to human B56alpha. Xenopus B56gamma is 94% identical with human B56gamma, however, a novel evolutionarily conserved mixed-isoform transcript was identified that contains a B56delta-like amino-terminal domain and a B56gamma core domain. The B56delta-like variable domain exon is located upstream of the B56gamma variable domain exon at the human B56gamma locus, suggesting that the mixed-isoform transcript is due to alternative splicing. B56gamma transcripts with different 3' ends were identified that lack or possess a 35 base pair sequence, resulting in either a transcript similar to human B56gamma1, or an uncharacterized evolutionarily conserved sequence. Real time RT-PCR analyses revealed that B56alpha is expressed at moderate levels before the midblastula transition (MBT), at reduced levels during gastrulation and neurulation, and at high levels during organogenesis, while B56gamma is expressed at low levels until organogenesis. B56alpha is enriched in the ventral hemisphere pre-MBT, while B56gamma is ventrally enriched post-MBT. Aalpha, Abeta, Calpha and Cbeta are expressed in early Xenopus development, suggesting the presence of a functional heterotrimer.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
Our data suggest that B56 functional diversity is achieved in part through the synthesis of a novel mixed-isoform B56delta/gamma transcript. Our data also suggest that B56alpha functions pre-MBT, inhibiting Wnt signaling on the ventral side of the embryo, and again during organogenesis, while B56gamma functions primarily post-MBT.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 424 425 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 426 427 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 502 503 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 730 731 692 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1013 1014 972 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1015 1016 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1301 1309 1248 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1367 1368 1314 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1369 1371 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Wnt ligands can activate canonical or planar cell polarity Wnt pathways. In canonical signaling, Wnt activates beta-catenin-dependent transcription via a phosphorylation-regulated signal transduction cascade. In the absence of Wnt, casein kinase Ialpha (CKIalpha) primes beta-catenin by phosphorylating Ser45, which is required for glycogen synthase kinase 3beta (GSK3beta) to phosphorylate three upstream Ser/Thr residues [1,2]. GSK3beta also phosphorylates adenomatous polyposis coli (APC) and axin [3]. GSK3beta, beta-catenin, APC, and axin comprise the core components of the beta-catenin degradation complex. APC and axin promote the interaction of GSK3beta with beta-catenin, and therefore also promote its phosphorylation [4]. Phosphorylated beta-catenin is ubiquitinated and degraded by the proteasome. When Wnt binds to LRP5/6 and frizzled (fz) coreceptors, an intracellular signaling cascade is activated that includes axin binding to LRP5/6, and disheveled (dsh/dvl) phosphorylation and binding to fz [5-7]. These events lead to destabilization of the beta-catenin degradation complex, reduced beta-catenin phosphorylation, and increased beta-catenin abundance. beta-catenin then forms a complex with a Lef/Tcf transcription factor, activating transcription of dorsalizing factors in early Xenopus development and cell cycle regulators in mammalian cells [8-10].
###end p 9
###begin p 10
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 663 665 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 666 668 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 621 626 <span type="species:ncbi:9606">human</span>
Although phosphorylation cascades have been intensely studied, relatively little is known about the role that phosphatases play in them. Phosphatase catalytic subunits are bound to targeting and regulatory subunits in multimeric complexes. PP2A is an abundantly expressed Ser/Thr phosphatase that has roles in DNA replication, cell cycle control, apoptosis, development, and tumorigenesis [11]. The inhibition of PP2A can cause cell proliferation and aberrant development. The phosphatase inhibitor okadaic acid induces skin and gastrointestinal tract cancers, and four mutations in a PP2A subunit, Aalpha, identified in human tumors, have reduced PP2A function [12-14].
###end p 10
###begin p 11
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 837 839 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 954 956 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1504 1506 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 466 472 <span type="species:ncbi:9606">humans</span>
###xml 908 913 <span type="species:ncbi:9606">human</span>
PP2A is comprised of a structural A, catalytic C, and regulatory B subunit. The B subunit confers substrate specificity and subcellular localization on the PP2A holoenzyme [15,16]. There are three distinct families of B subunits: B55, B56, and PR72. There may be as many as sixty distinct PP2A holoenzymes, since the A and C subunits, as well as each B subunit family, are encoded by multiple genes. B56 is the largest family of B regulatory subunits [15,17-20]. In humans, B56 is encoded by five highly related and widely expressed genes (B56alpha, B56beta, B56gamma, B56delta, and B56epsilon) that share a 71-88% identical 400 amino acid central core domain and highly variable amino- and carboxy-terminal extensions. The B56 family consists of two subfamilies based on amino acid similarity, B56alpha/beta/epsilon and B56delta/gamma [15]. The three-dimensional structure of a PP2A heterotrimer containing human B56gamma1 has recently been determined [21]. B56gamma1 forms eight pseudo-HEAT repeats (named for the four founding proteins: huntington, elongation factor 3, PP2A A, and TOR1), each of which is comprised of two antiparallel alpha-helices connected by intra-repeat loops. B56gamma1 binds to the A subunit through the "basal" surface of pseudo-HEAT repeats 2, 4, and 6, and to the C subunit through its intra-repeat loops. The B56 subunit is proposed to bring about isoform specificity both through its amino- and carboxy-termini and through the "apical" surface of its pseudo-HEAT repeats [21].
###end p 11
###begin p 12
###xml 278 280 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 791 800 738 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 993 995 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1183 1185 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1186 1188 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1400 1402 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1556 1567 1446 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1597 1599 1487 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">IP</sup>
###xml 1645 1655 1535 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 1925 1927 1815 1817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1943 1951 1833 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 2157 2159 2041 2043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1556 1566 <span type="species:ncbi:7227">Drosophila</span>
###xml 1571 1580 <span type="species:ncbi:7955">zebrafish</span>
###xml 1645 1655 <span type="species:ncbi:7227">Drosophila</span>
###xml 1812 1821 <span type="species:ncbi:7955">zebrafish</span>
B56alpha/beta/epsilon subfamily members have roles in both canonical and planar cell polarity Wnt signaling. In many cases, B56 is inhibitory to canonical Wnt signaling. B56alpha reduces beta-catenin abundance and Wnt-dependent gene expression in multiple experimental systems [22]. B56alpha's ability to reduce beta-catenin abundance depends on the phosphatase activity of PP2A, since the inhibition of this activity in mammalian cells results in increased beta-catenin abundance. Importantly, PP2A B56alpha, A, and C subunits each reduce Xwnt-8-induced secondary axes, suggesting that B56alpha increases B56alpha-specific PP2A activity rather than reducing nonB56alpha activity by sequestration of the PP2A AC heterodimer. In addition, B56alpha reduces the half-life of beta-catenin in an in vitro beta-catenin degradation assay, and the increased half-life of beta-catenin in the absence of PP1 and PP2A catalytic subunits is restored by the addition of the C subunit of PP2A, but not PP1 [23]. Epistasis and coimmunoprecipitation data suggest that PP2A:B56alpha is a component of the beta-catenin degradation complex, and that CKIdelta/epsilon dissociates PP2A from the complex [23,24]. In addition, DeltaNp63, an oncogenic p53 paralog, appears to activate Wnt signaling through its ability to bind to B56alpha in the absence of other PP2A subunits, preventing B56alpha from activating GSK3beta [25]. Wdb, a B56alpha/beta/epsilon family member most closely related to B56epsilon, influences both canonical and planar cell polarity Wnt signaling during Drosophila and zebrafish development. WdbIP, a partial loss-of-function allele of wdb in Drosophila, causes wing and eye outgrowths in a homozygous state, indicative of excessive Wnt signaling, while morpholino antisense oligonucleotides (MOs) against two zebrafish wdb genes together induce planar cell polarity defects at a low dose and dorsalization at a high dose [26]. In contrast, Xenopus B56epsilon activates canonical Wnt signaling, functioning between Wnt and dsh/dvl to positively regulate Wnt signaling in dorsal development, midbrain-hindbrain boundary formation, and neural tube closure [27].
###end p 12
###begin p 13
###xml 190 192 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 309 311 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 312 314 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 315 317 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 473 481 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 519 521 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 693 695 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 793 801 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 824 839 805 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1030 1045 985 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 424 429 <span type="species:ncbi:9606">human</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
###xml 824 838 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 1030 1044 <span type="species:ncbi:8355">Xenopus laevis</span>
There is growing evidence that B56gamma functions as a tumor suppressor. A B56gamma deletion mutant is unable to dephosphorylate paxillin, and enhances cell spreading as well as metastasis [28]. The small t DNA tumor virus antigen (sm t) enhances cell growth through inhibition of B56-specific PP2A activity [12,29-31]. In fact, the B56gamma binding site of sm t is required for sm t to activate Wnt signaling and transform human papilloma virus-infected keratinocytes, an in vivo model of cervical cancer progression [32]. In mouse, the transgenic overexpression of B56gamma in lung tissue reduces beta-catenin abundance and disrupts distal lung differentiation, resulting in neonatal death [33]. To better understand the distinct roles of the B56 family of PP2A regulatory subunits in early Xenopus development, we cloned Xenopus laevis B56alpha, analyzed B56alpha and B56gamma sequences, and undertook a quantitative analysis of the expression of B56alpha, B56gamma, and B56epsilon using real time RT-PCR on RNA collected from Xenopus laevis embryos at several points in development in both whole and hemisected embryos. We found dynamic and dissimilar expression patterns, reinforcing the hypothesis that B56alpha, B56gamma, and B56epsilon have distinct roles in development and in their ability to influence Wnt signaling.
###end p 13
###begin title 14
Results
###end title 14
###begin p 15
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 94 102 94 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 136 142 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopu</italic>
###xml 247 253 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopu</italic>
###xml 487 489 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 236 242 <span type="species:ncbi:9606">humans</span>
###xml 597 603 <span type="species:ncbi:9606">humans</span>
To facilitate our study of the role of B56 subunits during Xenopus development, a full-length Xenopus B56alpha cDNA was isolated from a Xenopus maternal cDNA library using human B56alpha as a probe. B56alpha is highly conserved between humans and Xenopus, the protein sequences are 88% identical and 92% similar overall. The proteins are more conserved in the core domain (93% identity) than in the amino- and carboxy-terminal variable domains (66% and 46% identity, respectively) (Fig. 1A). This high level of sequence conservation suggests the conservation of B56alpha function between frog and humans.
###end p 15
###begin p 16
###xml 13 28 13 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 0 68 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of <italic>Xenopus laevis </italic>and human B56&#945; and B56&#947; proteins</bold>
###xml 285 286 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 301 316 293 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 367 368 355 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 383 398 371 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 13 27 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 301 315 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 317 319 <span type="species:ncbi:8355">Xl</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
###xml 332 334 <span type="species:ncbi:9606">Hs</span>
###xml 383 397 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 399 401 <span type="species:ncbi:8355">Xl</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 414 416 <span type="species:ncbi:9606">Hs</span>
Alignment of Xenopus laevis and human B56alpha and B56gamma proteins. Dark blue regions signify identity, light blue regions signify similarity, and dashes signify gaps. The amino-terminal variable domain is boxed in green, while the carboxyl-terminal variable domain is boxed in red. A. Sequences of Xenopus laevis (Xl) and human (Hs) B56alpha proteins are aligned. B. Sequences of Xenopus laevis (Xl) and human (Hs) B56gamma proteins are aligned.
###end p 16
###begin p 17
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 201 209 189 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 544 559 516 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 901 916 837 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1184 1199 1104 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 1470 1473 1366 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2AB</xref>
###xml 1627 1629 1515 1517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1772 1790 1652 1670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 1859 1861 1739 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 544 558 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 901 915 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 1184 1198 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 1341 1346 <span type="species:ncbi:9606">human</span>
###xml 1449 1454 <span type="species:ncbi:9606">human</span>
###xml 1545 1550 <span type="species:ncbi:9606">human</span>
###xml 1593 1598 <span type="species:ncbi:9606">human</span>
###xml 1772 1790 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1792 1798 <span type="species:ncbi:9606">humans</span>
###xml 1800 1810 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1812 1825 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 1827 1832 <span type="species:ncbi:10090">mouse</span>
###xml 1834 1837 <span type="species:ncbi:10116">rat</span>
###xml 1843 1852 <span type="species:ncbi:7955">zebrafish</span>
We identified a Xenopus B56gamma cDNA from sequence databases that has 94% identity and 96% similarity to human B56gamma1. The core domain is highly related to human B56gamma1 (98% identical), but the Xenopus and human genes are divergent at their amino- and carboxy-termini (15% and 38% identity, respectively). When the amino-terminus was examined more closely, we found that it had higher identity to B56delta than to B56gamma, and we termed this mixed-isoform transcript B56delta/gamma. Sequence databases were then screened for additional Xenopus laevis B56gamma sequences, and a B56gamma cDNA clone was found that had a B56gamma-like amino-terminus (B56gamma/gamma). To verify that B56delta/gamma and B56gamma/gamma were representative of actual mRNA transcripts and were not cloning artifacts, RT-PCR was carried out with RNA from stage 32 embryos with upstream primers specific for either the Xenopus laevis B56delta or B56gamma 5' variable domain, and a downstream primer specific to the B56gamma core domain. The sequencing data obtained with the products from each of these reactions concur with our initial findings and suggest the presence of two B56gamma transcripts in Xenopus laevis with alternative 5' ends. The B56delta/gamma mixed-isoform transcript encodes an 82 amino acid amino-terminal domain that is 66% identical to human B56delta, while the B56gamma/gamma transcript encodes a 19 amino acid domain that is 89% identical to human B56gamma (Fig. 2AB). In both cases, the core domain is identical, and has 98% identity to human B56gamma, compared to 89% identity to the human B56delta core domain. (Fig. 1B and data not shown). A search of sequence databases identified seven species that possess this novel mixed-isoform B56delta/gamma transcript: Xenopus tropicalis, humans, chimpanzee, rhesus monkey, mouse, rat, and zebrafish (Fig. 2C). Therefore, this novel B56delta/gamma transcript is evolutionarily conserved.
###end p 17
###begin p 18
###xml 0 66 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Alignment of B56&#947; amino- and carboxy-terminal variable domains</bold>
###xml 128 129 124 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 144 159 140 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 226 227 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 242 257 226 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 324 325 296 297 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 340 355 312 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 361 380 333 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 831 832 787 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 954 973 906 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 144 158 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 242 256 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 340 354 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 356 358 <span type="species:ncbi:8355">Xl</span>
###xml 361 379 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 434 448 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
###xml 477 479 <span type="species:ncbi:9606">Hs</span>
###xml 495 507 <span type="species:ncbi:10090">Mus musculus</span>
###xml 528 545 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 570 581 <span type="species:ncbi:7955">Danio rerio</span>
###xml 954 972 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 988 1000 <span type="species:ncbi:10090">Mus musculus</span>
###xml 1016 1033 <span type="species:ncbi:10116">Rattus norvegicus</span>
###xml 1050 1064 <span type="species:ncbi:9544">Macaca mulatta</span>
###xml 1081 1086 <span type="species:ncbi:9606">human</span>
###xml 1102 1113 <span type="species:ncbi:7955">Danio rerio</span>
Alignment of B56gamma amino- and carboxy-terminal variable domains. Sequence alignments are annotated as described in Figure 1. A. Alignment of Xenopus laevis B56delta/gamma and human B56delta amino-terminal variable domains. B. Alignment of Xenopus laevis B56gamma/gamma and human B56gamma amino-terminal variable domains. C. Alignment of Xenopus laevis (Xl), Xenopus tropicalis (Xt, GI:39645667), Pan troglodyte (Pt, GI:114654932), Macaca mulatta (Mm2, GI:109084945), human (Hs, GI:47077243), Mus musculus (Mm1, GI:37359748), Rattus norvegicus (Rn, GI:109478743), and Danio rerio (Dn, GI:113674011) B56delta/gamma sequences from the B56delta-like amino-terminal variable region through the first ten amino acids of the B56gamma core domain. The division between the variable domain and the core domain is marked by an arrowhead. D. Alignment of an alternative long form of the B56gamma carboxy-terminal variable domain with the species described in C; Xenopus tropicalis (GI:45361341), Mus musculus (GI:71153488), Rattus norvegicus (GI:109478743), Macaca mulatta (GI:109084945), human (GI:31083259), Danio rerio (GI:113674011), Pan troglodyte (GI:114607473).
###end p 18
###begin p 19
###xml 334 336 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 426 441 390 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 798 800 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 947 949 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
###xml 426 440 <span type="species:ncbi:8355">Xenopus laevis</span>
To further study the origin of the mixed-isoform B56delta/gamma transcript, we examined the human genome database. The human B56delta 5' variable domain upstream of the B56gamma core is distinct from the human B56delta 5' variable domain upstream of the B56delta core, being 51% identical, and therefore is termed B56delta-like (Fig. 3A). In fact, the human B56delta and B56delta-like sequences are more highly related to the Xenopus laevis sequence than each other, suggesting that the B56delta and B56gamma genes are the result of a duplication of the B56delta/gamma gene. If the novel mixed-isoform B56delta/gamma transcript is the result of alternative splicing of the B56gamma gene, then the B56delta-like 5' variable domain should be present on chromosome 14p32.2, where B56gamma is located [34]. Indeed, the B56delta-like 5' variable domain is present on chromosome 14p32.2 in an exon upstream of the B56gamma 5' variable domain exon (Fig. 3B). The B56delta/gamma mixed-isoform transcript is thus a splice-variant from the B56gamma locus.
###end p 19
###begin p 20
###xml 0 108 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The B56&#948;-like amino-terminal variable domain is distinct from B56&#948; and encoded at the B56&#947; locus</bold>
###xml 110 111 98 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 263 264 243 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 113 118 <span type="species:ncbi:9606">Human</span>
###xml 132 137 <span type="species:ncbi:9606">human</span>
###xml 611 616 <span type="species:ncbi:9606">human</span>
The B56delta-like amino-terminal variable domain is distinct from B56delta and encoded at the B56gamma locus. A. Human B56delta and human B56delta-like amino-terminal variable domains are 51% identical. Sequence alignments are annotated as described in Figure 1. B. The exon encoding the B56delta-like amino-terminal variable domain (Exon 1a, light blue and dark blue bars represent noncoding and coding sequences, respectively) is upstream of the exon encoding the B56gamma amino-terminal variable domain (Exon 1b, light green and dark green bars represent noncoding and coding sequences, respectively) in the human B56gamma gene (chromosome 14p32.2). The introns are represented by lines and are shown in scale with one another, but not in scale with the exons.
###end p 20
###begin p 21
###xml 45 60 45 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 344 363 307 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 443 462 406 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 466 480 429 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 494 513 457 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 646 660 609 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 675 690 638 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 755 774 718 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis </italic>
###xml 984 986 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 987 989 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1000 1011 923 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropicalis </italic>
###xml 1094 1101 1014 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">laevis </italic>
###xml 1104 1115 1024 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropicalis </italic>
###xml 1137 1149 1053 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio </italic>
###xml 1256 1264 1164 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1334 1342 1238 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 45 59 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 344 362 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 443 461 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 466 480 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 494 512 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 646 660 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 675 689 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 694 699 <span type="species:ncbi:9606">human</span>
###xml 755 773 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 1137 1148 <span type="species:ncbi:7955">Danio rerio</span>
Our data, and that of others, has shown that Xenopus laevis possesses B56alpha, B56gamma (both B56delta/gamma and B56gamma/gamma), and B56epsilon orthologs. In addition, we found a partial cDNA of B56beta (XDB3.2 clone number rXL259o17ex) but we were unable to find evidence of expression of a B56delta core domain. Since the sequencing of the Xenopus tropicalis genome is near completion, and because of the high level of relatedness between Xenopus tropicalis and Xenopus laevis, we searched Xenopus tropicalis sequences to determine its complement of B56 genes, with the expectation that this is likely to also represent the B56 complement in Xenopus laevis. We used both Xenopus laevis and human B56 isoform sequences to screen sequence databases for Xenopus tropicalis B56 genes. We found B56alpha, B56gamma (both B56delta/gamma and B56gamma/gamma), B56epsilon, and B56beta orthologs, but no isoform with a B56delta core domain. B56beta is expressed most highly in adult brains [17,35], and the tropicalis B56beta was sequenced from an adult brain cDNA library. Although we did not find a laevis or tropicalis B56delta core domain, Danio rerio does possess a B56delta sequence containing the B56delta core domain (GI:40353001), suggesting either that Xenopus has a B56delta core domain but it has not yet been sequenced, or that Xenopus has lost this gene.
###end p 21
###begin p 22
###xml 123 125 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 181 196 165 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 270 272 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 570 588 530 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus tropicalis</italic>
###xml 708 710 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 766 768 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 181 195 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 248 253 <span type="species:ncbi:9606">human</span>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 570 588 <span type="species:ncbi:8364">Xenopus tropicalis</span>
###xml 590 596 <span type="species:ncbi:9606">humans</span>
###xml 598 608 <span type="species:ncbi:9598">chimpanzee</span>
###xml 610 623 <span type="species:ncbi:9544">rhesus monkey</span>
###xml 625 631 <span type="species:ncbi:9913">bovine</span>
###xml 633 636 <span type="species:ncbi:9615">dog</span>
###xml 638 644 <span type="species:ncbi:9913">bovine</span>
###xml 646 652 <span type="species:ncbi:9986">rabbit</span>
###xml 654 659 <span type="species:ncbi:10090">mouse</span>
###xml 661 664 <span type="species:ncbi:10116">rat</span>
###xml 666 673 <span type="species:ncbi:9031">chicken</span>
###xml 692 701 <span type="species:ncbi:7955">zebrafish</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
Alternative splicing occurs at the 3' end of human B56gamma, resulting in B56gamma1, B56gamma2, and B56gamma3 transcripts [34]. We found two alternative forms for the 3' end of the Xenopus laevis B56gamma transcript. One isoform is most similar to human B56gamma1 (Fig. 1B). The second form has an insertion of thirty-five nucleotides downstream of the core domain that leads to a frame-shift. The resulting open reading frame does not have significant identity to the 3' end of human B56delta, B56gamma1, B56gamma2, or B56gamma3. However, this sequence is conserved in Xenopus tropicalis, humans, chimpanzee, rhesus monkey, bovine, dog, bovine, rabbit, mouse, rat, chicken, puffer fish, and zebrafish (Fig. 2D and data not shown), and is expressed in mouse testis [36]. Therefore, this alternative 3' end of the B56gamma transcript is also evolutionarily conserved.
###end p 22
###begin p 23
###xml 71 79 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 301 309 285 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 578 580 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Knowledge of where and when B56alpha and B56gamma are expressed during Xenopus development will aid in our understanding of their role in Wnt signaling. To determine the expression pattern of B56alpha and B56gamma, real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was carried out on Xenopus embryos at several stages in early development. The expression patterns of B56alpha and B56gamma were compared to that of B56epsilon, whose expression pattern has previously been reported, so that even slight differences in their expression patterns could be detected [27].
###end p 23
###begin p 24
###xml 792 794 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E</xref>
###xml 929 937 859 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1254 1256 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1360 1362 1282 1284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1774 1776 1660 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 1870 1872 1750 1752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1948 1956 1824 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
Because B56 genes are members of a highly conserved family, we first verified that the primer pairs that we designed were isoform specific. We designed B56alpha, B56gamma, or B56epsilon primer pairs to amplify their 3' variable regions. We also designed B56gamma primer pairs to amplify either the B56delta-like or B56gamma 5' variable regions. The B56gamma primer pair at the 3' end of the gene amplified all of the B56gamma transcripts identified here: transcripts with either the B56delta-like or B56gamma 5' variable regions, as well as both the short and long 3' alternative splicing products. Real-time PCR was then performed with each B56 primer pair and B56alpha, B56gamma, or B56epsilon plasmid templates. Each primer pair specifically amplified only the corresponding isoform (Fig. 4E). These isoform-specific primer pairs were then used to examine the expression pattern of B56alpha, B56gamma, and B56epsilon in early Xenopus development. B56alpha is expressed at approximately 45% of the stage 32 value prior to MBT (egg - stage 7), at approximately 10% of the stage 32 value during gastrula and neurula stages (stages 10 - 19), and its expression gradually increased to its highest expression level during organogenesis (stages 23-32) (Fig. 4A). The expression level of all of the B56gamma transcripts described here was highest at stage 32 (Fig. 4C). B56gamma expression was approximately 25% of the stage 32 value from the egg to neurula stages (egg to stage 19), and increased during organogenesis. The B56delta/gamma transcript was expressed at moderate levels until organogenesis, while B56gamma/gamma was not significantly expressed until neurulation, while B56delta/gamma and B56gamma/gamma both displayed increased expression during organogenesis (Fig. 4D). The expression level of B56epsilon was relatively unchanged from the egg to stage 32 (Fig. 4B). This data suggests that B56alpha has at least two functions during early Xenopus development, one during cleavage stages and another during organogenesis. In contrast, B56gamma/gamma appears to have its primary function during organogenesis, while B56delta/gamma may function throughout early development.
###end p 24
###begin p 25
###xml 64 72 56 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 83 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B56&#945; and B56&#947; are differentially expressed during early <italic>Xenopus </italic>development</bold>
###xml 107 122 99 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 285 286 277 278 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 539 540 527 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 627 628 609 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 788 789 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1084 1085 1030 1031 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 107 121 <span type="species:ncbi:8355">Xenopus laevis</span>
B56alpha and B56gamma are differentially expressed during early Xenopus development. RNA was purified from Xenopus laevis embryos at the indicated stages, and real time RT-PCR was carried out. A standard curve was done from stage 32 embryos, and signals were normalized to that stage. A. B56alpha is expressed at approximately 45% of the stage 32 value prior to MBT, at approximately 10% of the stage 32 value during gastrula and neurula stages, and its expression gradually increases to its highest expression level during organogenesis. B. The expression level of B56epsilon is relatively unchanged from the egg to stage 32. C. The expression level of B56gamma is highest during organogenesis and is approximately 25% of that value during earlier stages (unfertilized egg to stage 19). D. The mixed-isoform B56delta/gamma transcript is expressed at moderate levels until organogenesis (dark blue bars), while B56gamma/gamma is not significantly expressed until neurulation (light blue bars); both B56delta/gamma and B56gamma/gamma display increased expression during organogenesis. E. A dose response curve of real time RT-PCR amplification data shows that B56alpha, B56gamma, and B56epsilon primer pairs are isoform specific. Input plasmid DNA concentrations are plotted against their concentration calculated from the amplification of the correct primer pair/template combination.
###end p 25
###begin p 26
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 391 406 363 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 839 841 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 974 982 890 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1227 1231 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A&#8211;C</xref>
###xml 1368 1370 1270 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 1456 1464 1358 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1593 1601 1481 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 391 405 <span type="species:ncbi:8355">Xenopus laevis</span>
If B56 subunits function as regulatory subunits of PP2A heterotrimers during Xenopus development as we hypothesize, then the A and C subunits should be concurrently expressed. Vertebrates possess two A isoforms, Aalpha and Abeta, as well as two C isoforms, Calpha and Cbeta. We carried out real time RT-PCR to examine the expression patterns of Aalpha, Abeta, Calpha, and Cbeta during early Xenopus laevis development. Because the A and C isoforms are highly conserved (the coding regions of Aalpha and Abeta are 73% identical, and Calpha and Cbeta are 79% identical), we first performed real-time PCR with Aalpha, Abeta, Calpha, and Cbeta primer pairs and Aalpha, Abeta, Calpha, or Cbeta plasmid templates to verify the isoform specificity of our primer pairs. Each primer pair specifically amplified only the corresponding isoform (Fig. 5E). These isoform-specific primer pairs were then used to examine the expression pattern of Aalpha, Abeta, Calpha, and Cbeta in early Xenopus development. Aalpha was expressed at low levels until organogenesis, whereas Abeta and Calpha were expressed at moderate levels from the egg through gastrulation, and at progressively increasing levels during neurulation and organogenesis (Fig. 5A-C). Cbeta was expressed at similar levels from the egg to stage 32, with the exception of its reduced expression during neurulation (Fig. 5D). Therefore, each of the components of the PP2A heterotrimer is present during early Xenopus development, suggesting that competent PP2A heterotrimers containing B56alpha, B56gamma, and B56epsilon are present during early Xenopus development.
###end p 26
###begin p 27
###xml 80 88 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 99 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PP2A A&#945;, A&#946;, C&#945;, and C&#946; are differentially expressed during early <italic>Xenopus </italic>development</bold>
###xml 123 138 109 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 301 302 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 365 369 344 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 380 384 355 359 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 516 517 491 492 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 647 648 619 620 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 123 137 <span type="species:ncbi:8355">Xenopus laevis</span>
PP2A Aalpha, Abeta, Calpha, and Cbeta are differentially expressed during early Xenopus development. RNA was purified from Xenopus laevis embryos at the indicated stages, and real time RT-PCR was carried out. A standard curve was done from stage 32 embryos, and signals were normalized to that stage. A. Aalpha is expressed at low levels until organogenesis. Abeta (B) and Calpha (C) are expressed at moderate levels through gastrulation, and at progressively increasing levels during neurulation and organogenesis. D. Cbeta is expressed at similar levels from the egg to stage 32, with the exception of its reduced expression during neurulation. E. A dose response curve of real time RT-PCR amplification data shows that Aalpha, Abeta, Calpha, and Cbeta primer pairs are isoform specific. Input plasmid DNA concentrations are plotted against their concentration calculated from the amplification of the correct primer pair/template combination.
###end p 27
###begin p 28
###xml 66 74 66 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 240 248 240 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 849 851 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1087 1096 1056 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A&#8211;D, F&#8211;I</xref>
###xml 1290 1294 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D,E</xref>
To further explore the expression pattern of PP2A subunits during Xenopus development, we localized their expression by real-time RT-PCR analyses of hemisected embryos. In general, RNA is more abundant in the animal hemisphere of the early Xenopus embryo because yolk plasm in the vegetal hemisphere reduces cytoplasmic volume. Total RNA, as well as poly(A)+ RNA, is two to four fold more abundant animally versus vegetally [37,38]. This differential distribution of RNA continues into gastrula stage embryos [37]. However, a number of maternal RNAs are differentially localized beyond, or contrary to, this inclination on the animal/vegetal axis. RNAs that will become germ plasm constituents or RNAs required for proper cell fate decisions, such as Vg1, are enriched vegetally [39]. Other RNAs, such as Tcf-1 and beta-TrCP, are enriched animally [39]. We analyzed the expression of PP2A subunits in animal/vegetal hemisected embryos. B56alpha, B56gamma, B56epsilon, Aalpha, Abeta, Calpha, and Cbeta were animally enriched approximately 4-fold at stage 7 and 1.5-fold at stage 10 (Fig. 6A-D, F-I). Ornithine decarboxylase (ODC), a housekeeping gene, had a similar distribution, whereas Vg1, a dissection marker, was vegetally enriched approximately nine-fold at each of these stages (Fig. 6D,E). Therefore, the PP2A subunits that we examined, like most maternal RNAs, are enriched in the animal hemisphere.
###end p 28
###begin p 29
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PP2A subunits are enriched in the animal hemisphere of <italic>Xenopus </italic>embryos</bold>
###xml 72 87 72 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 505 513 475 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 72 86 <span type="species:ncbi:8355">Xenopus laevis</span>
PP2A subunits are enriched in the animal hemisphere of Xenopus embryos. Xenopus laevis embryos at stages 7 and 10 were hemisected into animal and vegetal halves. RNA was purified from the hemisected halves and real time RT-PCR was carried out. The data is presented as the percentage of the total signal that is present in the specified hemisphere +/- SD. B56alpha (A), B56gamma (B), B56epsilon (C), Aalpha (F), Abeta (G), Calpha (H), and Cbeta (I) are enriched in the animal hemisphere of stage 7 and 10 Xenopus embryos. Dissection control ODC (D) is enriched animally, while Vg1 (E) is enriched vegetally. A = animal, V = vegetal.
###end p 29
###begin p 30
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 601 603 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 746 748 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 749 751 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 752 754 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1286 1287 1252 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1403 1405 1369 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 1408 1410 1374 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1411 1413 1377 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
RNA is not equally distributed dorsoventrally in Xenopus embryos. Total RNA is much higher in the dorsalmost region of the embryo at stage 3, while poly(A)+ RNA is equally distributed in the ventral and dorsal halves, causing a higher poly(A)+ to total RNA ratio on the ventral side of the embryo [37]. Several RNAs display differential dorsal/ventral localization during early Xenopus development [40]. In stage 5 embryos, for example, EF1alpha, goosecoid, and noggin are enriched on the dorsal side of the embryo, while Wnt8b is ventrally enriched, where it is required to inhibit dorsal cell fate [40]. Since B56 subunits influence dorsoventral body axis formation, we determined if there are any dorsoventral differences in their expression [23,27,33]. We carried out real-time RT-PCR on ventral/dorsal hemisected embryos at stages 3, 7, and 10 to determine if B56alpha or B56gamma are differentially localized during dorsoventral axis specification, as well as to localize Aalpha/beta and Calpha/beta expression. We found that most of the examined PP2A subunits were relatively equally distributed dorsoventrally, or were slightly higher dorsally. However, B56alpha at stage 3 and B56gamma at stage 10 are an exception to this pattern, since they are more abundant ventrally (Fig. 7). Dissection markers Vg1 (stage 3) and Xnr6 (stages 7 and 10) were 2.5 - 4 fold higher dorsally, as expected (Fig. 7D, [41,42]). These expression patterns suggest that B56alpha may be inhibiting Wnt activity on the ventral side of the embryo in the initial stages of dorsal axis specification, whereas B56gamma may carry out this function post-MBT. However, the magnitude of the differential localizations of B56alpha and B56gamma is not large, and posttranscriptional mechanisms may also play a role in the spatial regulation of PP2A:B56 heterotrimers in the early embryo.
###end p 30
###begin p 31
###xml 50 58 50 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The dorsoventral distribution of PP2A subunits in <italic>Xenopus </italic>embryos</bold>
###xml 67 82 67 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 67 81 <span type="species:ncbi:8355">Xenopus laevis</span>
The dorsoventral distribution of PP2A subunits in Xenopus embryos. Xenopus laevis embryos at stages 3, 7, and 10 were hemisected into dorsal and ventral halves. RNA was purified from the hemisected halves and real time RT-PCR was carried out. The data were normalized to ODC expression levels, and are presented as the percentage of the total signal present in the specified hemisphere. PP2A A and C subunits Aalpha (E), Abeta (F), Calpha (G), and Cbeta (H) are relatively equally distributed dorsoventrally or slightly enriched dorsally. However, B56alpha (A) at stage 3 and B56gamma (B) at stage 10 are more abundant ventrally. Dissection controls Vg1 (stage 3) and Xnr6 (stages 7 and 10) are enriched dorsally (D). D = dorsal, V = ventral.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 111 126 90 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 200 215 171 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 307 309 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 359 374 317 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 537 539 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 540 542 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 563 574 517 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Danio rerio</italic>
###xml 610 617 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink">laevis </italic>
###xml 620 630 574 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tropicalis</italic>
###xml 715 723 669 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 6 <span type="species:ncbi:9606">Humans</span>
###xml 111 125 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 200 214 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 359 373 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 563 574 <span type="species:ncbi:7955">Danio rerio</span>
Humans possess five B56 family members: B56alpha, B56beta, B56gamma, B56delta, and B56epsilon. We isolated the Xenopus laevis B56alpha gene and characterized B56gamma transcripts present during early Xenopus laevis development. We also found a partial B56beta cDNA; B56epsilon has previously been isolated [43]. The B56delta core domain has not been found in Xenopus laevis cDNA library sequences from public databases, suggesting that it is not present in early stage embryos. The B56delta core domain is highly expressed in the brain [35,44], and is present in Danio rerio, but has not yet been sequenced in laevis or tropicalis, suggesting that the appropriate adult library may not have been sequenced, or that Xenopus has lost the B56delta gene.
###end p 33
###begin p 34
###xml 342 349 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 529 531 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 549 563 533 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 722 730 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 331 337 <span type="species:ncbi:9606">humans</span>
###xml 450 455 <span type="species:ncbi:9606">human</span>
###xml 549 563 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 711 717 <span type="species:ncbi:9606">humans</span>
B56 proteins are comprised of a conserved central core domain and divergent amino- and carboxy-terminal extensions. The core interacts with the highly conserved A and C subunits, while the variable domains provide substrate specificity by binding diverse substrates. B56alpha and B56gamma core domains are highly conserved between humans and Xenopus, while the amino- and carboxy-terminal extensions are less well conserved. In fact, each residue in human B56alpha and B56gamma that interacts directly with the A and C subunits [21] is identical in Xenopus laevis. The relative conservation of the core domains and divergence of the amino- and carboxy-terminal variable domains of B56alpha and B56gamma between humans and Xenopus is likely to reflect their interactions with disparate types of protein binding partners: the core interacting with A and C subunits, and the amino- and carboxy-terminal domains interacting with substrates, proteins that are not likely to be as highly conserved as the A and C subunits.
###end p 34
###begin p 35
###xml 243 258 235 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 243 257 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 483 489 <span type="species:ncbi:9606">humans</span>
Our data suggest that diversity of B56 function is achieved in part through the synthesis of alternative transcripts that result in distinct amino- and carboxy-terminal domains. We identified a novel mixed-isoform B56delta/gamma transcript in Xenopus laevis comprised of a B56delta-like amino-terminal variable domain and a B56gamma core domain, as well as a B56gamma transcript possessing an alternative 3' end. Each of these variants is evolutionarily conserved, and is present in humans. The intense conservation of these novel B56gamma transcripts suggest that they are functional, because if they were not functional, their sequence would rapidly drift away from the consensus. The identification of a mixed-isoform B56delta/gamma transcript suggests that alternative splicing leads to a "fine-tuning" of PP2A substrate specificity.
###end p 35
###begin p 36
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 325 333 325 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 721 729 715 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 742 744 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 836 844 830 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1249 1257 1229 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1735 1737 1703 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1641 1646 <span type="species:ncbi:10090">mouse</span>
The expression of several B subunits during Xenopus development has been examined. Northern blotting analyses show that the B55 subunit is present at constant levels from the egg to metamorphosis, and present in the adult in the ovary, testis, muscle, and liver [45]. The expression of multiple PR72 isoforms was examined in Xenopus oocytes and adult tissues by hybridization detection of RT-PCR products [46]. XPR130 is expressed at low levels in the oocyte and at higher levels in the liver, gall bladder, spleen, heart, and muscle, while XPR70 is expressed at high levels in oocytes and each of the tissues mentioned above. B56epsilon, which is required for Wnt signaling, is expressed maternally and throughout early Xenopus development [27]. Its expression is uniform in the embryo until MBT, when its expression, as determined by in situ hybridization, becomes localized to the dorsal marginal zone in early gastrulation and expands to the entire marginal zone during midgastrulation. B56epsilon is expressed in the neural ectoderm during neurulation and in the eyes and branchial arches in the tadpole. We demonstrate here that B56alpha and B56gamma, both of which have Wnt-inhibitory activities, display dynamic expression patterns in early Xenopus development. B56alpha is expressed at moderate levels before MBT, when it may inhibit Wnt pathway activity on the ventral side of the embryo, at reduced levels during gastrulation and neurulation, and at high levels during organogenesis, while B56gamma is expressed at moderate levels until organogenesis. B56gamma has been shown to have a crucial role during lung development in the mouse, which is consistent with our finding that it is highly expressed during organogenesis [33].
###end p 36
###begin p 37
###xml 69 77 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 164 172 143 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 474 476 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 623 625 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 875 877 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 885 889 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C&#8211;D</xref>
###xml 944 952 884 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 1118 1120 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1302 1304 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1537 1539 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1863 1867 1772 1776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A&#8211;B</xref>
###xml 1972 1980 1867 1875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
Prior to this report, Abeta and Calpha were known to be expressed in Xenopus embryos, however, we detected Aalpha, Abeta, Calpha, and Cbeta expression during early Xenopus development. PP2A A and C subunit expression has previously been examined by Northern and western blotting. PP2A Calpha and Cbeta were both undetectable until stage 35 by Northern blotting, when Calpha is expressed at higher levels than Cbeta; in adults, they are most abundant in the ovary and heart [47]. However, a more recent report using Northern blotting shows that Calpha is expressed at similar levels from the egg through the gastrula stage [48]. Our results concur with these findings, but show that both Calpha and Cbeta RNAs are present in the egg and throughout early development. Calpha and Cbeta expression increases during organogenesis, when Van Hoof et al. first detected expression ([47], Fig. 5C-D). The expression of PP2A Aalpha and Abeta isoforms in Xenopus has previously been studied by western blotting, where it was found that Abeta is expressed in the oocyte and both Aalpha and Abeta are expressed in skeletal muscle [49], and by Northern blotting, where it was found that Abeta is expressed at similar levels from the oocyte to metamorphosis, whereas Aalpha expression is undetectable until stage 35 [45]. In adults, Abeta is highly expressed in the ovary, but expressed at reduced levels in all other tissues examined, while Aalpha is highly expressed in muscle, heart, and testes, and moderately expressed in liver, lung, and spleen [45]. Our results concur with these findings, but presumably due to the increased sensitivity of real-time RT-PCR as compared to Northern blotting, Aalpha was found to be expressed at low levels prior to organogenesis, after which its expression sharply increased, while expression was relatively more constant for Abeta (Fig. 5A-B). Since PP2A functions as a heterotrimer, the presence of Aalpha/beta and Calpha/beta isoforms in early Xenopus development suggests that B56alpha and B56gamma, as well as any other B subunits expressed during this time, will associate with A and C subunits, forming a functional heterotrimer.
###end p 37
###begin p 38
###xml 311 313 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 314 316 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 592 594 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 738 740 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1007 1009 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
The enrichment of B56alpha RNA on the ventral side of a 4 cell-stage embryo, against the trend of the A and C subunits to be enriched dorsally or equally distributed, suggests that B56alpha's ventral enrichment is significant. This, along with our previous data showing that B56alpha can inhibit Wnt signaling [22,23], suggest that B56alpha is functioning pre-MBT in ventral cells to inhibit dorsal cell fate. Other pre-MBT dorsoventral asymmetries exemplified by ventral enrichment have been identified. Wnt8b is enriched ventrally at the 16 cell-stage, where it represses dorsal cell fate [40]. Dorsal-specific signaling does occur pre-MBT, since Wnt-dependent transcription of Xnr5 and Xnr6 is detected as early as the 256 cell-stage [42]. The enrichment of B56gamma RNA on the ventral side of the embryo at stage 10, again against the trend of the A and C subunits to be enriched dorsally or equally distributed, suggests that this enrichment is significant. B56gamma can reduce beta-catenin abundance [33], therefore its ventral enrichment suggests that B56gamma functions post-MBT to inhibit Wnt signaling. Further tests will be required to determine if there is a requirement for ventral enrichment of B56alpha and B56gamma in specifying dorsoventral cell fate, such as antisense morpholino oligonucleotide microinjections, which are currently underway.
###end p 38
###begin p 39
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 905 907 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
Distinct PP2A heterotrimers may act on different substrates, or at multiple sites within a given substrate, with opposing consequences. Wnt signaling is regulated by phosphorylation at multiple points. Numerous kinases influence Wnt signaling, and each phosphorylation step carried out by a kinase is likely to have a counterregulatory dephosphorylation step carried out by a phosphatase. Consequently, there are likely to be as many phosphatases acting in the pathway as kinases. In contrast to the plethora of kinases, there are a limited number of phosphatase catalytic subunits. Diversity of phosphatase function is achieved through variation in the bound regulatory subunit. Since PP2A is one of the most abundant phosphatases, it is reasonable to expect that PP2A has multiple roles in the pathway. Evidence from our lab and others suggest that this is the case even within the B56 family [23,27,33,43,50].
###end p 39
###begin p 40
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 871 872 848 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 873 874 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 875 877 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
The PR72 family plays an important role in Wnt signaling. PR72 inhibits Wnt signaling through its interaction with Nkd, another Wnt inhibitor, and promotes dsh degradation [51]. Another PR72 family member, PR130, also binds to Nkd [52]. The binding of PR130 and PR72 to Nkd may be mutually exclusive, with PR72 inhibiting Wnt signaling when bound to Nkd due to its promotion of dsh degradation, and PR130 activating Wnt signaling when bound to Nkd by preventing Nkd-mediated Wnt inhibition. There are other gene families important to Wnt signaling in which different members of the gene family affect the pathway differently. For instance, CKIalpha inhibits the pathway by promoting beta-catenin degradation through the phosphorylation of beta-catenin's Ser45, while CKIdelta/epsilon activates the pathway, possibly by destabilizing the beta-catenin degradation complex [1,2,24]. Therefore, the regulation of Wnt signaling is clearly complex and cannot be completely understood until the roles of multigene families that influence it have been characterized.
###end p 40
###begin p 41
###xml 49 64 41 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 298 300 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 301 303 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 304 306 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 455 457 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 458 460 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 786 794 758 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 814 822 786 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 49 63 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
The expression of B56alpha and B56gamma in early Xenopus laevis development suggests that their regulation of PP2A activity at this time may influence Wnt signaling. It is of interest to note that PP2A A subunit mutations have been identified in human melanomas and colon, breast, and lung tumors [13,53-57]. Interestingly, two PP2A Aalpha mutant proteins initially identified in human cancers bind every PP2A subunit at near wild-type levels except B56 [13,14]. This suggests that the loss of B56-specific PP2A activity is involved in tumorigenesis, and since B56alpha and B56gamma can inhibit Wnt signaling, this suggests that the regulation of Wnt signaling by PP2A may be a critical factor in tumorigenesis. Future studies include the localization of B56alpha and B56gamma in early Xenopus development through in situ hybridization, which will enhance our knowledge of the spatiotemporal expression patterns of B56alpha and B56gamma, and B56alpha and B56gamma loss-of-function assays, each of which will help us understand in more detail how B56alpha and B56gamma influence Wnt signaling.
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
The activity of PP2A is regulated by the bound B subunit. The B56 family of B subunits has five genes in mammals, and our data suggest that diversity of B56 function is obtained in part through alternative splicing of the 5' and 3' variable domains. We found that the B56gamma transcript can be comprised of either a B56delta-like or B56gamma 5' variable domain, and either a B56gamma1-like or a novel conserved sequence for its 3' variable domain. Our data also suggest that B56alpha functions preMBT, inhibiting Wnt signaling on the ventral side of the embryo, and again during organogenesis, while B56gamma functions primarily during organogenesis.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Library screening and plasmids
###end title 45
###begin p 46
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 301 316 297 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 387 395 373 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 0 14 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 301 315 <span type="species:ncbi:8355">Xenopus laevis</span>
Xenopus laevis maternal cDNA library in pBluescript SK+ (A. Zorn) was screened with digoxygenin-labeled human B56alpha synthesized by PCR, and detected with DIG Luminescent Detection Kit (Roche, Indianapolis, IN). Positive clones were sequenced by primer walking (Macrogen, Seoul, Korea). Full length Xenopus laevis B56gamma and B56epsilon genes cloned in pSPORT6 were obtained from the Xenopus Gene Collection in the I.M.A.G.E. consortium through American Type Culture Collection (ATCC); GenBank accession number of B56alpha: , B56gamma: , B56epsilon: .
###end p 46
###begin title 47
RT-PCR and sequence analysis of B56gamma transcripts
###end title 47
###begin p 48
###xml 264 266 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 305 307 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
RT-PCR was performed with cDNA from stage 32 embryos with the primers XlB56gamma2U 5'-CCT CTT TTC CGG CAG CTA G-3' and XlB56gamma2D 5'-TTC CAT TGC AAC AGG ACT-3'. PCR products were sequenced (Macrogen, Seoul, Korea). Sequence analysis was performed with ClustalW [62] and The Sequence Manipulation Suite [63].
###end p 48
###begin title 49
Real-time RT-PCR
###end title 49
###begin p 50
To verify the isoform specificity of the B56alpha, B56gamma, B56epsilon, Aalpha, Abeta, Calpha, and Cbeta primer pairs, real-time PCR was performed using plasmid templates. Plasmid concentrations of each family member were used (0.5 to 5 pg/mul, except B56gamma (3'end): 0.5 - 2.5 pg/mul) that exceed the signals obtained with the cDNA samples as determined by their Cp values. A 20 mul reaction included 1.8 to 3 muM primers, 10 mul of 2x SYBR master mix, 2 mul of template, and 0.5 units of Uracil-DNA glycosylase (New England Biolabs, Beverly, MA). Real-time RT-PCR was done using QuantiTech SYBR green PCR kit (Qiagen, Valencia, CA) in the LightCycler 2.0 (Roche, Indianapolis, IN). The reaction program consisted of four steps: pre-incubation, quantitation, melting curve analysis, and cooling. Data analysis was performed by LightCycler 4.0 software (Roche, Indianapolis, IN). The data were plotted using the standard curve obtained using the correct DNA/primer pair combination.
###end p 50
###begin p 51
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
Embryos were collected at different stages of development [58]. Total RNA was extracted from embryos using Trizol solution and a chloroform, isopropanol-tRNA solution. RNA was washed with 70% ethanol and resuspended in 125 mul of DEPC-treated water per 10 embryos. cDNA synthesis was done using 1 mug of total RNA with SuperScript III First-Strand Synthesis SuperMix and random hexamers (Invitrogen, Carlsbad, CA) following manufacturer's instructions. For stage-specific expression, a dilution series of stage 32 cDNA was used to generate a standard curve to determine relative cDNA concentrations and signals were normalized to stage 32; error bars represent +/- one standard deviation.
###end p 51
###begin p 52
###xml 879 881 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 965 967 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 1057 1059 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
The following primers were used: XlB56alpha (U: 5'-TCA TAC AAA GCA GAG CGA-3', D: 5'-TTC TGC ACA CAG AGA GTA GG-3'), XlB56gamma (U: 5'-TGC AGC TAA GAT TTT GCC-3', D: 5'-TTC CAT TGC AAC AGG ACT-3'), XlB56delta/gamma (U: 5'-ACT CCA CAG GCT GTT GTT-3', D: 5'-CAG GTC ACT TAG AGG ATC AGA-3'), XlB56gamma/gamma (U: 5'-ATG GTG GTA GAT GCA GCT AA-3', D: 5'-CAG GTC ACT TAG AGG ATC AGA-3'), XlB56epsilon (U: 5'-ATT CAA ACG TCG TCC TTC-3', D: 5'-CCA TCA CTC CTA AGA CCT CTC-3'), XPR65alpha (U: 5'-GGG GAC CTT TAC TTC ATT G-3', D: 5'-CTC ATG AGA AAT GGC ACG-3'), XPR65beta (U: 5'-GGG AAG CTT CAC CAG TCT T-3', D: 5'-TTC CTC AAG GAG TCC ACT G-3'), XC36alpha (U: 5'-GAG GGC CAG GTC AAG AGT-3', D: 5'-TCA TGA TTT CCT CGG AGG-3'), XC36beta (U: 5'-GGA AAC CAG GCA GCT ATT-3', D: 5'-AAG GCA TCG TGT AAA GAT TG-3'), Vg1 (U: 5'-CCA TAC CCG CTG ACA GAA AT-3', D: 5'-CCT GCA GCC ACA CTC ATC TA-3') [59], Xnr6 (U: 5'-AAG ATT GGA TGG GGT CAT CA-3', D: 5'-ATC AGC ATG GAC AAG GGA CT-3') [60], ODC (U: 5'-GCC ATT GTG AAG ACT CTC TCC ATT C-3', D: 5'-TTC GGG TGA TTC CTT GCC AC-3') [61].
###end p 52
###begin title 53
Embryo dissections
###end title 53
###begin p 54
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Embryos were hemisected at stages 3, 7, and 10. The planes of hemisection were determined based on pigmentation differences for all animal/vegetal hemisections, as well as stage 3 dorsal/ventral hemisections. Stage 7 dorsal/ventral hemisection were done using embryos marked with Nile blue at stage 3, and stage 10 dorsal/ventral hemisections were done based on the location of the dorsal blastopore lip. Real-time RT-PCR was carried out on hemisected halves of embryos as described above using equal amounts of total RNA. Vg1 was used as a vegetal marker, as well as a dorsal marker for stage 3, while Xnr6 was used as a dorsal marker for stages 7 and 10 [41,42]. In each dissection, standard curves were generated using the dissected half with the higher expression level. For dorsoventral-specific expression, signals were normalized to ODC expression, while animal/vegetal dissection signals are presented directly.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
SB participated in experimental design, and carried out the library screening and real time RT-PCR. JMS conceived of the study, participated in experimental design, and drafted the manuscript. Both authors read and approved the final manuscript.
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
###xml 27 42 27 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis </italic>
###xml 27 41 <span type="species:ncbi:8355">Xenopus laevis</span>
We thank A. Zorn for a pBS Xenopus laevis maternal cDNA library, J. Goris for Xenopus Aa, Ab, Ca, and Cb plasmids, and S. Sokol and A. Branscomb for critically reading the manuscript. This work was supported by grants from NSF (MCB-0642067) and The City University of New York PSC-CUNY Research Award Program.
###end p 58
###begin article-title 59
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism
###end article-title 59
###begin article-title 60
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway
###end article-title 60
###begin article-title 61
###xml 34 39 <span type="species:ncbi:9606">human</span>
Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta
###end article-title 61
###begin article-title 62
Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin
###end article-title 62
###begin article-title 63
###xml 61 71 <span type="species:ncbi:7227">Drosophila</span>
The dishevelled protein is modified by wingless signaling in Drosophila
###end article-title 63
###begin article-title 64
LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way
###end article-title 64
###begin article-title 65
Direct binding of the PDZ domain of Dishevelled to a conserved internal sequence in the C-terminal region of Frizzled
###end article-title 65
###begin article-title 66
Identification of c-MYC as a target of the APC pathway
###end article-title 66
###begin article-title 67
###xml 81 86 <span type="species:ncbi:9606">human</span>
Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
###end article-title 67
###begin article-title 68
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
###end article-title 68
###begin article-title 69
Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling
###end article-title 69
###begin article-title 70
###xml 106 110 <span type="species:ncbi:10116">rats</span>
An alternative theory of tissue specificity by tumor promotion of okadaic acid in glandular stomach of SD rats
###end article-title 70
###begin article-title 71
###xml 139 144 <span type="species:ncbi:9606">human</span>
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms
###end article-title 71
###begin article-title 72
###xml 60 65 <span type="species:ncbi:9606">human</span>
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene
###end article-title 72
###begin article-title 73
The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm
###end article-title 73
###begin article-title 74
###xml 74 89 <span type="species:ncbi:10633">simian virus 40</span>
Different oligomeric forms of protein phosphatase 2A activate and inhibit simian virus 40 DNA replication
###end article-title 74
###begin article-title 75
Identification of a new family of protein phosphatase 2A regulatory subunits
###end article-title 75
###begin article-title 76
###xml 14 19 <span type="species:ncbi:9606">human</span>
Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --> p12
###end article-title 76
###begin article-title 77
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae homologs of mammalian B and B' subunits of protein phosphatase 2A direct the enzyme to distinct cellular functions
###end article-title 77
###begin article-title 78
The variable subunit associated with protein phosphatase 2A0 defines a novel multimember family of regulatory subunits
###end article-title 78
###begin article-title 79
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
###end article-title 79
###begin article-title 80
Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A
###end article-title 80
###begin article-title 81
Protein phosphatase 2A and its B56 regulatory subunit inhibit Wnt signaling in Xenopus
###end article-title 81
###begin article-title 82
Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex
###end article-title 82
###begin article-title 83
DeltaNp63 induces beta-catenin nuclear accumulation and signaling
###end article-title 83
###begin article-title 84
Planar cell polarization requires Widerborst, a B' regulatory subunit of protein phosphatase 2A
###end article-title 84
###begin article-title 85
PP2A:B56epsilon is required for Wnt/beta-catenin signaling during embryonic development
###end article-title 85
###begin article-title 86
A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation
###end article-title 86
###begin article-title 87
###xml 19 23 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation
###end article-title 87
###begin article-title 88
###xml 94 98 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation
###end article-title 88
###begin article-title 89
###xml 54 59 <span type="species:ncbi:9606">human</span>
Identification of specific PP2A complexes involved in human cell transformation
###end article-title 89
###begin article-title 90
Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression
###end article-title 90
###begin article-title 91
Transgenic expression of protein phosphatase 2A regulatory subunit B56gamma disrupts distal lung differentiation
###end article-title 91
###begin article-title 92
Genomic organization and mapping of the gene encoding the PP2A B56gamma regulatory subunit
###end article-title 92
###begin article-title 93
High complexity in the expression of the B' subunit of protein phosphatase 2A0. Evidence for the existence of at least seven novel isoforms
###end article-title 93
###begin article-title 94
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Expression of the B56delta subunit of protein phosphatase 2A and Mea1 in mouse spermatogenesis. Identification of a new B56gamma subunit (B56gamma4) specifically expressed in testis
###end article-title 94
###begin article-title 95
The regional distribution of poly (A) and total RNA concentrations during early Xenopus development
###end article-title 95
###begin article-title 96
Identification and cloning of localized maternal RNAs from Xenopus eggs
###end article-title 96
###begin article-title 97
Putting RNAs in the right place at the right time: RNA localization in the frog oocyte
###end article-title 97
###begin article-title 98
Multiple maternal influences on dorsal-ventral fate of Xenopus animal blastomeres
###end article-title 98
###begin article-title 99
Vg 1 is an essential signaling molecule in Xenopus development
###end article-title 99
###begin article-title 100
Beta-catenin/Tcf-regulated transcription prior to the midblastula transition
###end article-title 100
###begin article-title 101
A positive role for the PP2A catalytic subunit in Wnt signal transduction
###end article-title 101
###begin article-title 102
###xml 66 71 <span type="species:ncbi:9606">human</span>
Molecular cloning of a 74-kDa regulatory subunit (B" or delta) of human protein phosphatase 2A
###end article-title 102
###begin article-title 103
###xml 60 74 <span type="species:ncbi:8355">Xenopus laevis</span>
The PR55 And PR65 subunits of protein phosphphatase 2A from Xenopus laevis: Molecular cloning and developmental regulation of expression
###end article-title 103
###begin article-title 104
###xml 80 94 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 201 206 <span type="species:ncbi:9606">human</span>
Identification and characterization of B"-subunits of protein phosphatase 2A in Xenopus laevis oocytes and adult tissues: Evidence for an independent N-terminal splice variant of PR130 and an extended human PR48 protein
###end article-title 104
###begin article-title 105
###xml 133 147 <span type="species:ncbi:8355">Xenopus laevis</span>
Molecular cloning and developmental regulation of expression of two isoforms of the catalytic subunit of protein phosphatase 2A from Xenopus laevis
###end article-title 105
###begin article-title 106
Identification of a C-rich element as a novel cytoplasmic polyadenylation element in Xenopus embryos
###end article-title 106
###begin article-title 107
###xml 72 78 <span type="species:ncbi:9986">rabbit</span>
Analysis of subunit isoforms in protein phosphatase 2A holoenzymes from rabbit and Xenopus
###end article-title 107
###begin article-title 108
Inhibition of the Wnt signaling pathway by the PR61 subunit of protein phosphatase 2A
###end article-title 108
###begin article-title 109
PR72, a novel regulator of Wnt signaling required for Naked cuticle function
###end article-title 109
###begin article-title 110
PR130 is a modulator of the Wnt-signaling cascade that counters the repression of the antagonist Naked cuticle
###end article-title 110
###begin article-title 111
Lessons from hereditary colorectal cancer
###end article-title 111
###begin article-title 112
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer
###end article-title 112
###begin article-title 113
###xml 54 59 <span type="species:ncbi:9606">human</span>
Beta-catenin mutations in cell lines established from human colorectal cancers
###end article-title 113
###begin article-title 114
###xml 35 40 <span type="species:ncbi:9606">human</span>
Alterations of the PPP2R1B gene in human lung and colon cancer
###end article-title 114
###begin article-title 115
PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers
###end article-title 115
###begin article-title 116
XPACE4 is a localized pro-protein convertase required for mesoderm induction and the cleavage of specific TGFbeta proteins in Xenopus development
###end article-title 116
###begin article-title 117
New roles for FoxH1 in patterning the early embryo
###end article-title 117
###begin article-title 118
Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach
###end article-title 118
###begin article-title 119
ClustalW
###end article-title 119
###begin article-title 120
The Sequence Manipulation Suite
###end article-title 120

